ImmuPharma plc (LON:IMM – Get Free Report)’s stock price was up 13.4% during trading on Wednesday . The stock traded as high as GBX 10.80 and last traded at GBX 10.50. Approximately 7,242,426 shares changed hands during trading, a decline of 10% from the average daily volume of 8,073,004 shares. The stock had previously closed at GBX 9.26.
ImmuPharma Price Performance
The business’s fifty day moving average price is GBX 10.98 and its two-hundred day moving average price is GBX 5.43. The stock has a market capitalization of £52.79 million, a PE ratio of -11.80 and a beta of 1.53.
About ImmuPharma
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
Featured Stories
- Five stocks we like better than ImmuPharma
- What is Forex and How Does it Work?
- Rare Earth Stocks: The Truce That Isn’t a Truce
- How to Buy Gold Stock and Invest in Gold
- Carving Up Profits: 3 Food Stocks on the Thanksgiving Table
- Are Penny Stocks a Good Fit for Your Portfolio?
- C3.ai’s Reset: Why New Leadership Could Spark a Turnaround
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
